Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention

BACKGROUND: The CYP2C19 nonfunctional genotype reduces clopidogrel effectiveness after percutaneous coronary intervention (PCI). Following clinical implementation of CYP2C19 genotyping at University Florida (UF) Health Shands Hospital in 2012, where genotype results are available approximately 3 day...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavallari, Larisa H., Franchi, Francesco, Rollini, Fabiana, Been, Latonya, Rivas, Andrea, Agarwal, Malhar, Smith, D. Max, Newsom, Kimberly, Gong, Yan, Elsey, Amanda R., Starostik, Petr, Johnson, Julie A., Angiolillo, Dominick J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896099/
https://www.ncbi.nlm.nih.gov/pubmed/29642909
http://dx.doi.org/10.1186/s12967-018-1469-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896099/
https://www.ncbi.nlm.nih.gov/pubmed/29642909
http://dx.doi.org/10.1186/s12967-018-1469-8

Ejemplares similares